Adaptive smartphone games can track thinking skills in people with MS and are enjoyable enough that people will likely keep using them.
Researchers put ten short cognitive games into a smartphone app and asked people to play twice a week for five weeks, then compared results to standard thinking tests. For nine of the ten games, scores matched fairly well with established paper-and-pencil tests, meaning the games were measuring similar mental abilities. Both people with MS and healthy volunteers got better at the games over the five weeks, which shows the games can detect change over time (this is called a practice effect). Participants rated the games as enjoyable and meaningful, which is important because people are more likely to keep using tools they like. The study suggests these adaptive games could be used to monitor thinking skills at home, but more and longer studies are needed to confirm this.
People living with MS should care because thinking problems are common in MS and these games offer a simple way to check mental skills from home, like using a fitness app for your brain. Caregivers may find this useful to notice subtle changes early, similar to spotting small shifts in mood or mobility before they become bigger problems. Neurologists and MS nurses might use game results to guide conversations about treatment, fatigue, or therapy, much like using a blood sugar log to manage diabetes. Employers and vocational counselors could use repeated game scores to understand work-related thinking challenges and plan supports, like adjusting tasks or schedules. Overall, anyone involved in daily care can get regular, easy-to-understand feedback on thinking skills without extra clinic visits.
The study was small (62 people total) and only ran for five weeks, so we don’t know how well the games work for many people or over months and years. People improved with practice, and while that shows the games detect change, it also means one must be careful to tell apart improvement from true recovery or decline. The games matched standard tests fairly well but are not a replacement for a full clinical evaluation; they are best used as a supplement or early warning tool.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds a brain‑seeking CD4 killer cell tied to MS and CMV exposure that may resist some treatme
Read More5/1/2026
Study shows after optic neuritis the ganglion cell layer (GCL) loses more tissue than the inner plex
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds specific spinal fluid proteins tied to early nerve damage in active MS, highlighting imm
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.